During the Trading Day
27.82 -0.94 / -3.27%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
27.82 0.00 / 0.00%
Volume: 5.5K
Health Technology

Company Description

TESARO, Inc. is an oncology-focused biopharmaceutical company. It is dedicated to improving the lives of cancer patients. The company's product portfolio currently consists of three oncology-related product candidates: Rolapitant, Niraparib and TSR-011. TESARO was founded by Leon Moulder, Jr., Mary Lynne Hedley and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA.

Contact Information

1000 Winter Street
Waltham Massachusetts 02451
P:(339) 970-0900
Investor Relations:
(781) 325-1116



Individual stakeholders45.24%
Mutual fund holders31.91%
Other institutional28.33%

Top Executives

Leon O. MoulderChief Executive Officer & Director
Mary Lynne HedleyPresident, Chief Operating Officer & Director
Timothy R. PearsonChief Financial Officer & Executive Vice President
Robert E. MartellChief Medical Officer
Lori Rudolph-OwenVP-Portfolio Management, Research & Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.